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higher angina readmission rate (28.6% vs 15.7%, P<0.01), and higher 1-
year mortality (19.0% vs 7.8%, P<0.01) in AMI patients with high PLR.
CONCLUSIONS Patients with AMI and high PLR have relatively worse
short-term prognosis than those with AMI and low PLR on admission.
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OBJECTIVES We hypothesize that the stage and underlying
morphologic characteristics of atherosclerotic lesions will inﬂuence
the vascular response to changes in plaque size. In this study, we
analyzed baseline OCT and serial IVUS images to investigate the in-
ﬂuence of baseline plaque characteristics on serial coronary remod-
eling in patients presenting with acute coronary syndrome (ACS).
METHODS One hundred and sixty seven ACS patients underwent
both OCT and IVUS examination of a non-culprit lesion after percu-
taneous coronary intervention to the culprit lesion. All patients sub-
sequently underwent repeat IVUS imaging at 12-month follow-up.
According to the plaque characteristics, the slope (b) of the regression
line relating EEM to plaque areas were compared by the Generalized
Estimating Equations (GEE).
RESULTS The change in EEM area for each mm2 change in plaque area
(i.e. slope of the regression line) was greater for ﬁbrous plaques
compared to non-ﬁbrous plaques but did not reach statistical signiﬁ-
cance (slopes: 1.48 vs. 1.04 mm2, p¼0.061). There was a trend towards
a smaller slope of the regression line in plaques with TCFA compared
to plaques without TCFA (slopes: 0.89 vs. 1.30 mm2, p¼0.070).
Notably, there was a statistically signiﬁcant difference in regression
line slope between lesions with and without calciﬁcation, with calci-
ﬁed lesions showing less change in EEM area relative to change in
plaque area (slopes: 0.67 vs. 1.47 mm2, p < 0.001). The slopes were not
signiﬁcantly affected by the presence or absence of microvessels
(p¼0.773), cholesterol crystals (p¼0.229), or macrophages (p¼0.950).
CONCLUSIONS The capacity for coronary artery remodeling in
response to plaque progression or regression varies among lesions
with different baseline characteristics. Lesions with OCT-identiﬁed
features associated with early-stage atherosclerosis showed a more
robust capacity for arterial remodeling compared to lesions with
advanced-stage atherosclerotic features.
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OBJECTIVES Large research programs have been focused on the
identiﬁcation of new risk factors to prevent CAD, with special atten-
tion to homocysteine (Hcy), due to the known associated increased
atherosclerosis, oxidative stress status and endothelial dysfunction.
However, controversy still exists on the association and prognostic
value between Hcy and CAD. Therefore, aim of the current study was
to investigate the prognostic value of Hcy in Chinese acute coronary
syndrome (ACS) octogenarians undergoing coronary angiography
(CAG).
METHODS We enrolled 660 consecutive ACS octogenarians who un-
derwent coronary angiography and were classiﬁed into three groups
according to Hcy tertiles. The baseline characters and Hcy level were
measured on admission. Survival and major adverse cardiac event
(MACE) rates were calculated using the Kaplan-Meier method. Multi-
variate Cox regression was used to identify mortality predictors. ROC
curve analysis was used to predict cut-off value of Hcy for mortality.
RESULTS There were 621 patients fulﬁlled the follow-up. The follow-
up period was 28 (IQR16-38) months. Diastolic blood pressure (DBP),
ratios of male, chronic renal failure (CRF) and history of myocardial
infarction were higher in high plasmatic level of Hcy (H-Hcy) group
than those in low (L-Hcy) and middle (M-Hcy) plasmatic level of Hcy
groups (P<0.05), but no remarkable difference in other conventional
risk factors (all P > 0.05). The Hcy level was positive correlated with
UA level (r¼0.211, P¼0.001) and cys C level (r¼0.212, P¼0.001) andinversely correlated with eGFR (r¼-0.148, P¼0.018). The cumulative
survival of H-Hcy group was signiﬁcantly lower than that of L-Hcy and
M-Hcy groups in the long term (P ¼ 0.006). All cause mortality and
MACE of H-Hcy group were higher than those of L-Hcy and M-Hcy
group (P¼0.0001, P¼0.0008). Hcy is an independent predictor for
long-term mortality(OR ¼ 2.26, 95% CI ¼ 1.23-4.16, P ¼ 0.023) and
MACE(OR ¼ 1.91, 95% CI ¼ 1.03-3.51, P ¼ 0.039). ROC curve analysis
showed that the predictive cut-off value of Hcy for mortality was
17.67mmol/L (0.667, 0.681).
CONCLUSIONS All cause mortality and MACE of ACS octogenarians
increased with the level of plasmatic Hcy, Hcy is an important pre-
dictor for long-term mortality and MACE of ACS octogenarians.
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OBJECTIVES This study sought to investigate whether pregnancy
associated plasma protein-A (PAPP-A) is useful for risk assessment in
elderly patients with non-ST segment elevation acute coronary syn-
drome (NSTE-ACS).
METHODS PAPP-A was measured in 455 elderly patients with non
NSTE-ACS, Study and followed-up for 12 months. A cut point was
according to the ROC curve, the patients was were divided into high
level group and low level group, to evaluate the association between
the PAPP-A and the incidence of the combined cardiovascular events.
RESULTS The cut point of PAPP-A was 23.5 MIU/ L, and the sensitivity
and speciﬁcity of the incidence of were 66.7% and 75.0% respectively.
Multivariate logistic regression analysis demonstrates that there was a
correlation between the PAPP-A level and rates of the combined car-
diovascular events (OR ¼ 2.83, P ¼ 0.006). The Cox proportional
hazards regression model shows PAPP-A is an independent risk factor
for prognosis of the combined cardiovascular events (HR ¼ 2.79, P ¼
0.007).
CONCLUSIONS PAPP-A was independently associated with recurrent
cardiovascular events in elderly patients with NSTE-ACS. PAPP-A may
be useful for risk assessment and monitoring in populations at high
risk of cardiovascular events.GW26-e3949
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OBJECTIVES We aimed to evaluate the safety and efﬁcacy of do-
mestic JC-extracorporeal shockwave myocardial revascularization(JC-
ESMR) therapy for refractory angina pectoris.
METHODS JC-ESMR adopts the optimal density of energy treatment
(0.09mJ/mm2), Electrocardiography(ECG) controlled shockwave
release, pulses are released only in refractory phase of the cardiac cycle,
it designs the ﬂexible, intelligent positioning system and Real-time
monitoring system under echocardiography. Eighteen patients with
medically refractory angina and no revascularization options were
randomly divided into 2 groups. The control group (n ¼ 10) received
only medical therapy. The treatment group(n¼8) were treated with JC-
ESMR (3 times a week at intervals of four weeks for a total of three
months, nine treatments patient in total). Efﬁcacy was assessed by CCS
grading of angina, dosage of nitroglycerin, NYHA classiﬁcation, as well
as ischemic burden on pharmacological SPECT at 4months after the last
JC-ESMR treatment. Safety measures included ECG, troponin, creatine
kinase, and pro- brain natriuretic peptide testing.
RESULTS The CCS grading of angina, dosage of nitroglycerin, NYHA
classiﬁcation were improved in treatment group compared to control
group. The perfusion evaluated by SPECT has improved statistically
signiﬁcant compared to control group. The JC-ESMR therapy was
performed safely without any adverse events in ECG, troponin, crea-
tine kinase, or pro- brain natriuretic peptide.
CONCLUSIONS This study demonstrates the JC-ESMR is a safe,
effective and non-invasive new treatment for patients with refractory
angina pectoris. However, larger sham-controlled trials will be
required to conﬁrm the clinical utility of this novel therapy.
